Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Income-Before-Tax" stands at 556.17 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Chugai Pharmaceutical Co. Ltd.'s second quarter result of 136.00 Billion JPY for the item "Income Before Tax" represents an increase of 0.13 percent compared to it's first quarter result.
Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 136.00 Billion JPY for the item "Income Before Tax" represents a decrease of -14.36 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 556.17 Billion JPY for the item "Income Before Tax" represents a decrease of -3.94 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.77 percent compared to the value the year prior.
The 1 year change in percent is 13.77.
The 3 year change in percent is 2.04.
The 5 year change in percent is 119.25.
The 10 year change in percent is 626.26.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Income Before Tax | 905,699,262,464.00 |
![]() | Johnson & Johnson - Income Before Tax | 486,508,953,600.00 |
![]() | AbbVie Inc - Income Before Tax | 399,570,305,024.00 |
![]() | Roche Holding AG - Income Before Tax | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Income Before Tax | 280,205,508,085.11 |